Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum
This pilot study shows lipidomic profiling by UHPSFC–MS can detect pancreatic cancer from blood samples with >95% accuracy and higher sensitivity than CA 19-9.
This week we bring you other document by Agilent Technologies and posters by Shimadzu / AOAC, Thermo Fisher Scientific / ASMS and Waters Corporation / AOAC!